BIG
IART icon

Bellwether Investment Group’s Integra LifeSciences IART Stock Holding History

Bellwether Investment Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-463
Closed -$20K – 308
2017
Q1 		$20K Sell
463
-13
-3% -$555 0.05% 309
2016
Q4 		$20K Buy
+476
New +$19.3K 0.02% 459

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellwether Investment Group's IART Position: Q2 2017 in Review

Bellwether Investment Group sold out of Integra LifeSciences (IART) in Q2 2017, closing a stake of 463 shares — an estimated $20K sold.

Bellwether Investment Group first reported a position in IART in Q4 2016 and held it in 2 quarters. The position peaked at $20K in Q1 2017. 223 funds tracked by Wall St. Rank hold IART as of Q2 2017.

  • Bellwether Investment Group reported no remaining Integra LifeSciences position as of Q2 2017 after selling out during the quarter.
  • Bellwether Investment Group sold 463 Integra LifeSciences shares in Q2 2017, an estimated $20K.
  • Bellwether Investment Group first reported a position in Integra LifeSciences in Q4 2016 and held it in 2 quarters.
  • Bellwether Investment Group's Integra LifeSciences position peaked at $20K in Q1 2017.
  • 223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2017.

Based on Bellwether Investment Group's 13F filing for Q2 2017, filed 8 Aug 2017.